Association of ALOX12 and ALOX15 gene polymorphisms with age at menarche and natural menopause in Chinese women

Menopause

Volumn 19, Issue 9, 2012, Pages 1029-1036

  Xiao, Wenjin ^a,b   Ke, Yaohua ^a   He, Jinwei ^a   Zhang, Hao ^a   Yu, Jinbo ^a   Hu, Weiwei ^a   Gu, Jiemei ^a   Yue, Hua ^a   Wang, Chun ^a   Hu, Yunqiu ^a   Li, Miao ^a   Fu, Wenzhen ^a   Liu, Yujuan ^a   Zhang, Zhenlin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Age at menarche; Age at natural menopause; ALOX12; ALOX15; Polymorphism

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE;

ADULT; ARTICLE; CHINESE; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUATION; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FATHERS; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MENARCHE; MENOPAUSE; MIDDLE AGED; MOTHERS; NUCLEAR FAMILY; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865795127     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31824e6160     Document Type: Article

References (54)

1. Jordan SJ, Webb PM, Green AC. Height, age at menarche, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005;14: 2045-2048.
2. Chang-Claude J, Andrieu N, Rookus M, et al. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev 2007;16:740-746.
3. Xu WH, Xiang YB, Ruan ZX, et al. Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer 2004;108:613-619.
4. Remsberg KE, Demerath EW, Schubert CM, Chumlea WC, Sun SS, Siervogel RM. Early menarche and the development of cardiovascular disease risk factors in adolescent girls: the Fels longitudinal study. J Clin Endocrinol Metab 2005;90:2718-2724.
5. Eastell R. Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol 2005;185:223-234.
6. Gerdhem P, Obrant KJ. Bone mineral density in old age: the influence of age at menarche and menopause. J Bone Miner Metab 2004;22:372-375.
7. Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS. Age at natural menopause and the risk of epithelial ovarian cancer. Obstet Gynecol 2001;98:85-90.
8. Velie EM, Nechuta S, Osuch JR. Lifetime reproductive and anthropometric risk factors for breast cancer in postmenopausal women. Breast Dis 2005;24:17-35.
9. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:341-354.
10. Karapanou O, Papadimitriou A. Determinants of menarche. Reprod Biol Endocrinol 2010;8:115.
11. Murabito JM, Yang Q, Fox C, Wilson PW, Cupples LA. Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab 2005;90:3427-3430.
12. Sirois J, Sayasith K, Brown KA, et al. Cyclooxygenase-2 and its role in ovulation: a 2004 account. Hum Reprod Update 2004;10:373-385.
13. Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997;91:197-208.
14. Matsumoto H, Ma W, Smalley W, Trzaskos J, Breyer R, Dey SK. Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biol Reprod 2011;64:1557-1565.
15. St-Louis I, Singh M, Brasseur K, Leblanc V, Parent S, Asselin E. Expression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroids. Reprod Biol Endocrinol 2010;8:103.
16. Feldman E, Haberman S, Abisogun AO, et al. Arachidonic acid metabolism in human granulosa cells: evidence for cyclooxygenase and lipoxygenase activity in vitro. Hum Reprod 1986;1:353-356.
17. Reich R, Kohen F, Naor Z, Tsafriri A. Possible involvement of lipoxygenase products of arachidonic acid pathway in ovulation. Prostaglandins 1983;26:1011-1020.
18. Mikuni M, Yoshida M, Hellberg P, et al. The lipoxygenase inhibitor, nordihydroguaiaretic acid, inhibits ovulation and reduces leukotriene and prostaglandin levels in the rat ovary. Biol Reprod 1998;58:1211-1216.
19. Kurusu S, Jinno M, Ehara H, Yonezawa T, Kawaminami M. Inhibition of ovulation by a lipoxygenase inhibitor involves reduced cyclooxygenase-2 expression and prostaglandin E2 production in gonadotropin-primed immature rats. Reproduction 2009;137:59-66.
20. HarslLf T, Husted LB, Nyegaard M, et al. Polymorphisms in the ALOX12 gene and osteoporosis. Osteoporos Int 2011;22:2249-2259.
21. Praticò D, Zhukareva V, Yao Y, et al. 12/15-Lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol 2004;164:1655-1662.
22. Burdon KP, Rudock ME, Lehtinen AB, et al. Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the Diabetes Heart Study. Mediators Inflamm 2010;2010: 170153.
23. Fürstenberger G, Krieg P, Müller-Decker K, Habenicht AJ. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 2006;119:2247-2254.
24. Liu P, Lu Y, Recker RR, Deng HW, Dvornyk V. ALOX12 gene is associated with the onset of natural menopause in white women. Menopause 2010;17:152-156.
25. Qin YJ, Shen H, Huang QR, et al. Estrogen receptor gene polymorphisms and peak bone density in Chinese nuclear families. J Bone Miner Res 2003;18:1028-1035.
26. Zhang ZL, He JW, Qin YJ, et al. Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families. Osteoporos Int 2008;19:39-47.
27. Yue H, He JW, Zhang H, et al. No association between polymorphisms of peroxisome [corrected] proliferator-activated receptor-F gene and peak bone mineral density variation in Chinese nuclear families. Osteoporos Int 2010:21:873-882.
28. Kelavkar U, Wang S, Montero A, Murtagh J, Shah K, Badr K. Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes. Mol Biol Rep 1998;25:173-182.
29. Urano T, Shiraki M, Fujita M, et al. Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5¶-flanking region (j5229G/A) with bone mineral density. J Bone Miner Metab 2005;23:226-230.
30. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68: 978-989.
31. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
32. Kistner EO, Infante-Rivard C, Weinberg CR. A method for using incomplete triads to test maternally mediated genetic effects and parentof-origin effects in relation to a quantitative trait. Am J Epidemiol 2006; 163:255-261.
33. Havill LM, Dyer TD, Richardson DK, Mahaney MC, Blangero J. The quantitative trait linkage disequilibrium test: a more powerful alternative to the quantitative transmission disequilibrium test for use in the absence of population stratification. BMC Genet 2005;6:S91.
34. Ichikawa S, Koller DL, Johnson ML, et al. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J Bone Miner Res 2006;21:556-564.
35. Liu Y-W, Arakawa T, Yamamoto S, Chang W-C. Transcriptional activation of human 12-lipoxygenase gene promoter is mediated through Sp1 consensus sites in A431 cells. Biochem J 1997;324:133-140.
36. Fridman C, Ojopi EP, Gregório SP, et al. Association of a new polymorphism in ALOX12 gene with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2003;253:40-43.
37. Guo Y, Zhang X, Tan W, et al. Platelet 12-lipoxygenase Arg261Gln polymorphism: Functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms. Pharmacogenet Genomics 2007;17:197-205.
38. Zhu X, Fejerman L, Luke A, Adeyemo A, Cooper RS. Haplotypes produced from rare variants in the promoter and coding regions of angiotensinogen contribute to variation in angiotensinogen levels. Hum Mol Genet 2005;14:639-643.
39. Emilsson L, Saetre P, Jazin E. Low mRNA levels of rgs4 splice variants in Alzheimer's disease: association between a rare haplotype and decreased mRNA expression. Synapse 2006;59:173-176.
40. Catalano A, Procopio A. New aspects on the role of lipoxygenases in cancer progression. Histol Histopathol 2005;20:969-975.
41. Tilly JL. Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol 2001;2:838-848.
42. Evans AC, Ireland JL, Winn ME, et al. Identification of genes involved in apoptosis and dominant follicle development during follicular waves in cattle. Biol Reprod 2004;70:1475-1484.
43. Brodowska A, Laszczyñska M, Starczewski A. Apoptosis in ovarian cells in postmenopausal women. Folia Histochem Cytobiol 2007;45:99-105.
44. Kok HS, van Asselt KM, van der Schouw YT, et al. Genetic studies to identify genes underlying menopausal age. Hum Reprod Update 2005; 11:483-493.
45. Guo AM, Liu X, Al-Wahab Z, et al. Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival. Cancer Chemother Pharmacol 2011;68:1273-1283.
46. Pidgeon GP, Lysaght J, Krishnamoorthy S, et al. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 2007;26:503-524.
47. Taketo MM, Sonoshita M. Phospolipase A2 and apoptosis. Biochim Biophys Acta 2002;1585:72-76.
48. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas 2000;35:3-9.
49. van Noord PA, Dubas JS, Dorland M, Boersma H, te Velde ER. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 1997;68:95-102.
50. van den Berg SM, Boomsma DI. The familial clustering of age at menarche in extended twin families. Behav Genet 2007;37:661-667.
51. Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009;19: 212-219.
52. McClellan J, King MC. Genetic heterogeneity in human disease. Cell 2010;141:210-217.
53. Riestra P, Garcia-Anguita A, Torres-Cantero A, Bayonas MJ, de Oya M, Garces C. Association of the Q223R polymorphism with age at menarche in the leptin receptor gene in humans. Biol Reprod 2011;84:752-755.
54. Zhao J, Xiong DH, Guo Y, Yang TL, Recker RR, Deng HW. Polymorphism in the insulin-like growth factor 1 gene is associated with age at menarche in Caucasian females. Hum Reprod 2007;22:1789-1794.